RedHill Biopharma reported $859K in Loan Capital for its fiscal quarter ending in June of 2026.





Loan Capital Change Date
Cara Therapeutics USD 0 0 Mar/2025
Clal Biotechnology ILS 25.96M 18.48M Dec/2023
Compugen USD 0 0 Dec/2024
RedHill Biopharma USD 859K 41K Jun/2026